| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Research Department, Pharmaceuticals Division, Ciba-Geigy Ltd., Basel, Switzerland.
Received November 1, 1994. Accepted in final form February 24, 1995.
Address correspondence and reprint requests to Dr Waldmeier, Research Department, Pharmaceuticals Division, Ciba-Geigy Ltd., K-125.607, CH-4002 Basel, Switzerland.
We compared the effects of the antiepileptic drugs carbamazepine, oxcarbazepine, and lamotrigine on the release from rat brain slices of endogenous glutamate, [(3) H]-GABA, and [(3) H]-dopamine, elicited by the Naplus channel opener, veratrine, and of the same transmitters as well as [(3) H]-noradrenaline, [(3) H]-5-hydroxytryptamine, and [(3) H]-acetylcholine, elicited by electrical stimulation. The three antiepileptic drugs inhibited veratrine-induced release of endogenous glutamate, [(3) H]-GABA, and [(3) H]-dopamine, with IC50 values between 23 and 150 micro Meter, in or near the concentration range in which they interact with Naplus channels, and there was little difference between the compounds. They were five to seven times less potent in inhibiting electrically as compared with veratrine-stimulated release of [(3) H]-GABA and [(3) H]-dopamine; similarly, carbamazepine and tetrodotoxin were more potent in inhibiting veratrine-induced as compared with electrically induced release of endogenous glutamate. Carbamazepine, oxcarbazepine, and lamotrigine also inhibited electrically stimulated release of [(3) H]-5-hydroxytryptamine (IC50 values, 150 to 250 micro Meter) and [(3) H]-acetylcholine (IC50 values, 50 to 150 micro Meter); [(3) H]-noradrenaline release was affected to a lesser degree. The active concentration ranges of these drugs with respect to inhibition of veratrine-stimulated neurotransmitter release matched the therapeutic plasma and brain concentrations. It is uncertain whether these effects are relevant in vivo at anticonvulsant doses, because the drugs are markedly less potent in inhibiting the more physiologic release elicited by electrical stimulation. Therefore, the hypothesis that inhibition of glutamate release is the mechanism of anticonvulsant action of lamotrigine (or carbamazepine and oxcarbazepine) is doubtful. Other consequences of Naplus channel blockade may have an important role.
NEUROLOGY 1995;45: 1097-1913
This article has been cited by other articles:
|
|
 |
|
  J. C. Ong, S. A. Brody, C. H. Large, and M. A. Geyer An Investigation of the Efficacy of Mood Stabilizers in Rodent Models of Prepulse Inhibition J. Pharmacol. Exp. Ther., December 1, 2005; 315(3): 1163 - 1171. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Anand, D. S. Charney, D. A. Oren, R. M. Berman, X. S. Hu, A. Cappiello, and J. H. Krystal Attenuation of the Neuropsychiatric Effects of Ketamine With Lamotrigine: Support for Hyperglutamatergic Effects of N-methyl-D-aspartate Receptor Antagonists Arch Gen Psychiatry, March 1, 2000; 57(3): 270 - 276. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Kremer, C. M. Clark, E. W. Almqvist, L. A. Raymond, P. Graf, C. Jacova, M. Mezei, M. A. Hardy, B. Snow, W. Martin, et al. Influence of lamotrigine on progression of early Huntington disease: A randomized clinical trial Neurology, September 1, 1999; 53(5): 1000 - 1000. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. P. Frizelle, D. C. Moriarty, and J. J. O'Connor The Combined Effects of Halothane and Lamotrigine on Excitatory Postsynaptic Potentials and Use-Dependent Block in the Rat Dentate Gyrus In Vitro Anesth. Analg., August 1, 1999; 89(2): 496 - 496. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Bittigau and C. Ikonomidou Topical Review: Glutamate in Neurologic Diseases J Child Neurol, November 1, 1997; 12(8): 471 - 485. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
